![]() Amylyx Amylyx Pharmaceuticals is a company engaged in the development of therapies for neurodegenerative and endocrine disorders. | Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. | ![]() Fujifilm Diosynth Biotechnologies Fujifilm Diosynth Biotechnologies U.S.A. is a contract development and manufacturing organization operating in the biopharmaceutical industry. | ![]() Chiesi Group Chiesi Group (Gruppo Chiesi, also known as CHIESI Farmaceutici) is a company that researches, develops, produces, and commercializes therapeutic solutions. | YiChang HEC ChangJiang Pharmaceutical YiChang HEC ChangJiang Pharmaceutical is a company that develops, manufactures, and sells pharmaceutical products. | |
Founding Date | Founding Date 2013 | Founding Date 1985 | Founding Date 2011 | Founding Date 1935 | Founding Date 2001 |
Type | Type Public | Type Public | Type Subsidiary | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations Cambridge, US HQ Bruxelles, BE Paris, FR Munich, DE Dublin, IE Termonfeckin, IE Amsterdam, NL see more | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN | Locations Morrisville, US HQ Hillerød, DK Stockton On Tees, GB College Station, US | Locations Parma, IT HQ Melbourne, AU Wien, AT Machelen, BE Santana De Parnaíba, BR São Paulo, BR Sofia, BG see more | Locations HQ |
Employees | Employees 13611% increase | Employees 9,067 | Employees 5,3942% increase | Employees 5,8541% increase | Employees 4,595 |
Valuation ($) | Valuation ($) 362.8 m | Valuation ($) 4.2 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥11.7b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) €2.4b (Y, 2021) | Revenue (est.) ¥3.7b (FY, 2024) |
Cost of goods | Cost of goods N/A | Cost of goods ¥4.1b (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥533.6m (FY, 2024) |
Gross profit | Gross profit N/A | Gross profit ¥7.8b (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit ¥3.2b (FY, 2024) |
Net income | Net income ($144.7m) (FY, 2025) | Net income ¥2.4b (FY, 2025) | Net income N/A | Net income N/A | Net income ¥482.7m (FY, 2024) |
Funding | |||||
Total funding raised | Total funding raised $ 170.5m | Total funding raised N/A | Total funding raised $ 850m | Total funding raised N/A | Total funding raised N/A |
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View company
Fujifilm Diosynth Biotechnologies U.S.A. is a contract development and manufacturing organization operating in the biopharmaceutical industry.
View company
Chiesi Group (Gruppo Chiesi, also known as CHIESI Farmaceutici) is a company that researches, develops, produces, and commercializes therapeutic solutions.
View companyYiChang HEC ChangJiang Pharmaceutical is a company that develops, manufactures, and sells pharmaceutical products.
View company